Kei Fukami

5.8k total citations
135 papers, 4.5k citations indexed

About

Kei Fukami is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kei Fukami has authored 135 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Clinical Biochemistry, 54 papers in Nephrology and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kei Fukami's work include Advanced Glycation End Products research (52 papers), Chronic Kidney Disease and Diabetes (29 papers) and Dialysis and Renal Disease Management (16 papers). Kei Fukami is often cited by papers focused on Advanced Glycation End Products research (52 papers), Chronic Kidney Disease and Diabetes (29 papers) and Dialysis and Renal Disease Management (16 papers). Kei Fukami collaborates with scholars based in Japan, United States and Australia. Kei Fukami's co-authors include Sho‐ichi Yamagishi, Seiya Okuda, Takanori Matsui, Seiji Ueda, Mark E. Cooper, Josephine M. Forbes, Masayoshi Takeuchi, Kensei Taguchi, Yusuke Kaida and Sayaka Maeda and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Kei Fukami

127 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kei Fukami Japan 35 2.0k 1.3k 1.0k 1.0k 719 135 4.5k
Seiji Ueda Japan 39 1.4k 0.7× 1.1k 0.8× 936 0.9× 949 0.9× 1.4k 2.0× 93 4.9k
Vicki Thallas‐Bonke Australia 22 1.4k 0.7× 784 0.6× 861 0.8× 902 0.9× 559 0.8× 31 3.0k
Jean‐Luc Wautier France 32 2.8k 1.4× 1.6k 1.2× 605 0.6× 1.2k 1.2× 1.2k 1.7× 93 5.8k
Sho‐ichi Yamagishi Japan 33 1.5k 0.7× 927 0.7× 347 0.3× 899 0.9× 580 0.8× 61 3.6k
Wendy C. Burns Australia 28 1.0k 0.5× 1.1k 0.8× 931 0.9× 1.3k 1.3× 268 0.4× 32 3.9k
Paul J. Beisswenger United States 32 2.4k 1.2× 1.7k 1.3× 405 0.4× 921 0.9× 857 1.2× 62 4.0k
Marta Kalousová Czechia 30 1.1k 0.5× 582 0.4× 505 0.5× 774 0.8× 428 0.6× 162 3.5k
Carmen Mora‐Fernández Spain 38 1.0k 0.5× 1.3k 1.0× 3.0k 2.9× 1.4k 1.4× 452 0.6× 101 6.3k
Keiji Isshiki Japan 38 604 0.3× 1.1k 0.9× 1.4k 1.3× 1.7k 1.7× 898 1.2× 73 5.1k
Sianna Panagiotopoulos Australia 35 836 0.4× 1.6k 1.2× 1.9k 1.9× 711 0.7× 375 0.5× 81 4.2k

Countries citing papers authored by Kei Fukami

Since Specialization
Citations

This map shows the geographic impact of Kei Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Fukami more than expected).

Fields of papers citing papers by Kei Fukami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Fukami. The network helps show where Kei Fukami may publish in the future.

Co-authorship network of co-authors of Kei Fukami

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Fukami. A scholar is included among the top collaborators of Kei Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Fukami. Kei Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taguchi, Kensei, Yuya Yamashita, Yosuke Nakayama, et al.. (2025). Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease. JCI Insight. 10(13). 2 indexed citations
2.
Kaida, Yusuke, Kensei Taguchi, & Kei Fukami. (2025). Carnitine Deficiency in Chronic Kidney Disease: Pathophysiology, Clinical Implications, and Therapeutic Perspectives. Nutrients. 17(13). 2084–2084.
3.
Taguchi, Kensei, et al.. (2025). Glucagon like peptide-1 modulates urinary sodium excretion in diabetic kidney disease via ENaC activation. Scientific Reports. 15(1). 11486–11486. 2 indexed citations
4.
Taguchi, Kensei, et al.. (2024). Three Cases of Red Yeast Rice–Containing Supplement-Induced Acute Kidney Injury and Fanconi Syndrome. American Journal of Kidney Diseases. 85(4). 522–526. 5 indexed citations
5.
Taguchi, Kensei, et al.. (2023). Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy. Internal Medicine. 62(21). 3203–3207.
6.
Taguchi, Kensei & Kei Fukami. (2023). RAGE signaling regulates the progression of diabetic complications. Frontiers in Pharmacology. 14. 1128872–1128872. 67 indexed citations
7.
Shibata, Tatsuhiro, Nagisa Morikawa, Shinichiro ITO, et al.. (2023). Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights. European Journal of Preventive Cardiology. 30(18). 1941–1949. 8 indexed citations
8.
Fujii, Makiko, et al.. (2022). Glomerular Microangiopathy in a Patient With Takayasu Arteritis. Journal of the American Society of Nephrology. 33(11S). 490–491.
9.
Fukami, Kei, Shingo Ata, Takeshi Yokoyama, et al.. (2022). Quantification and Visualization of Reliable Hemodynamics Evaluation Based on Non-Contact Arteriovenous Fistula Measurement. Sensors. 22(7). 2745–2745. 4 indexed citations
10.
Yano, Junko, Yusuke Kaida, Takashi Maeda, et al.. (2020). l‐carnitine supplementation vs cycle ergometer exercise for physical activity and muscle status in hemodialysis patients: A randomized clinical trial. Therapeutic Apheresis and Dialysis. 25(3). 304–313. 12 indexed citations
11.
Nakayama, Yosuke, Mikiko Soejima, Junko Yano, et al.. (2020). Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations. Clinical and Experimental Nephrology. 25(3). 251–260. 1 indexed citations
12.
13.
Taguchi, Kensei, Sho‐ichi Yamagishi, Miyuki Yokoro, et al.. (2018). RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice. Scientific Reports. 8(1). 2686–2686. 29 indexed citations
14.
Kaifu, Kumiko, Seiji Ueda, Nobutaka Nakamura, et al.. (2018). Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4. Microvascular Research. 120. 90–93. 23 indexed citations
15.
Kaida, Yusuke, Sho‐ichi Yamagishi, Hideharu Tanaka, et al.. (2017). L-carnitine Supplementation Improves Self-rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis. Letters in Drug Design & Discovery. 14(6). 737–742. 12 indexed citations
16.
Goto, Shunsuke, Kentaro Nakai, Jun Ito, et al.. (2014). Marked Elevation of Serum Hyaluronan Levels in Collagenofibrotic Glomerulopathy. Internal Medicine. 53(16). 1801–1804. 1 indexed citations
17.
Fukami, Kei, Sho‐ichi Yamagishi, Melinda T. Coughlan, et al.. (2014). Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy. Diabetology & Metabolic Syndrome. 6(1). 86–86. 31 indexed citations
18.
Fukami, Kei, Sho‐ichi Yamagishi, & Seiya Okuda. (2010). Development of Enzyme-Linked Immunosorbent Assay System for PEDF and its Clinical Utility. Current Molecular Medicine. 10(3). 317–320. 11 indexed citations
19.
Matsui, Takanori, Sho‐ichi Yamagishi, Masayoshi Takeuchi, et al.. (2009). Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Biochemical and Biophysical Research Communications. 385(2). 269–272. 44 indexed citations
20.
Matsuoka, Hidehiro, Nobuya Haramaki, Kei Fukami, et al.. (2005). Polymorphonuclear Leukocytes May Impair Endothelial Function. Arteriosclerosis Thrombosis and Vascular Biology. 25(6). 1262–1267. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiji Ueda Breakdown of academic impact, for papers by Vicki Thallas‐Bonke Breakdown of academic impact, for papers by Jean‐Luc Wautier Breakdown of academic impact, for papers by Sho‐ichi Yamagishi Breakdown of academic impact, for papers by Wendy C. Burns Breakdown of academic impact, for papers by Paul J. Beisswenger Breakdown of academic impact, for papers by Marta Kalousová Breakdown of academic impact, for papers by Carmen Mora‐Fernández Breakdown of academic impact, for papers by Keiji Isshiki Breakdown of academic impact, for papers by Sianna Panagiotopoulos
Rankless by CCL
2026